Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results

Cancer

Volumn 123, Issue 18, 2017, Pages 3502-3512

  Partin, Melissa R ^a,b   Gravely, Amy A ^a   Burgess, James F ^c,d   Haggstrom, David A ^e,f   Lillie, Sarah E ^a,b   Nelson, David B ^a,b   Nugent, Sean M ^a   Shaukat, Aasma ^a,b   Sultan, Shahnaz ^a,b   Walter, Louise C ^g   Burgess, Diana J ^a,b  

^a Minneapolis Veterans Affairs Health Care System   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

colonoscopy; colorectal neoplasms; diagnostic services; early detection of cancer; health services accessibility; mass screening; veterans health

Indexed keywords

ABNORMAL LABORATORY RESULT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; ATTITUDE TO HEALTH; BLACK PERSON; CANCER SCREENING; CAUCASIAN; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; DEMOGRAPHY; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH VARIATION; HISPANIC; HUMAN; INAPPROPRIATE SCREENING; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; OCCULT BLOOD TEST; PATIENT ATTITUDE; PATIENT FACTOR; PHYSICIAN ATTITUDE; PHYSICIAN FACTOR; PRIORITY JOURNAL; PRIVATE SECTOR COLONOSCOPY USE; SCREENING REFUSAL; SCREENING TEST; SEX DIFFERENCE; SOCIAL ASPECT; STAFF TRAINING; VERY ELDERLY; AGE; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; DOCTOR PATIENT RELATION; EARLY CANCER DIAGNOSIS; ENVIRONMENT; ETHNOLOGY; FACTUAL DATABASE; MULTIVARIATE ANALYSIS; OCCULT BLOOD; PROCEDURES; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; UNITED STATES;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; COLONOSCOPY; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; ENVIRONMENT; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCULT BLOOD; PHYSICIAN-PATIENT RELATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 85028998380     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30765     Document Type: Article

References (45)

1. American Cancer Society. Cancer Facts & Figures 2016. Atlanta, GA: American Cancer Society; 2016.
2. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564-2575.
3. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33:101-110.
4. El Serag HB, Petersen L, Hampel H, Richardson P, Cooper G. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006;166:2202-2208.
5. Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15:1232-1235.
6. Garman KS, Jeffreys A, Coffman C, Fisher DA. Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci. 2006;332:159-163.
7. Paszat L, Rabeneck L, Kiefer L, Mai V, Ritvo P, Sullivan T. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. Can J Gastroenterol. 2007;21:379-382.
8. Jimbo M, Myers RE, Meyer B, et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009;7:11-16.
9. Powell AA, Nugent S, Ordin DL, Noorbaloochi S, Partin MR. Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test. Med Care. 2011;49:897-903.
10. Chubak J, Garcia MP, Burnett-Hartman AN, et al. Time to colonoscopy after positive fecal blood test in 4 US health care systems. Cancer Epidemiol Biomarkers Prev. 2016;25:344-350.
11. Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100:418-424.
12. Oluloro A, Petrik AF, Turner A, et al. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. J Community Health. 2016;41:864-870.
13. Choi KS, Lee HY, Jun JK, Shin A, Park EC. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol. 2012;27:1070-1077.
14. Turner B, Myers RE, Hyslop T, et al. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med. 2003;18:357-363.
15. Correia A, Rabeneck L, Baxter NN, et al. Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices. Prev Med. 2015;76:115-122.
16. Rao SK, Schilling TF, Sequist TD. Challenges in the management of positive fecal occult blood tests. J Gen Intern Med. 2009;24:356-360.
17. Carlson CM, Kirby KA, Casadei MA, Partin MR, Kistler CE, Walter LC. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? Arch Intern Med. 2011;171:249-256.
18. Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ. Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration. Cancer. 2012;118:3345-3355.
19. Partin MR, Burgess DJ, Burgess JF Jr, et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomarkers Prev. 2015;24:422-434.
20. Myers RE, Hyslop T, Gerrity M, et al. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 1999;8:587-593.
21. Myers RE, Turner B, Weinberg D, et al. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings. Prev Med. 2001;33:249-260.
22. Austin PC, Tu JV. Boostrap methods for developing predictive models. Am Statistician. 2004;58:131-137.
23. Powell AA, Saini SD, Breitenstein MK, et al. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration. J Gen Intern Med. 2015;30:732-741.
24. Miglioretti DL, Rutter CM, Bradford SC, et al. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care. 2008;46:S91-S96.
25. Plumb AA, Ghanouni A, Rainbow S, et al. Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test. J Med Screen. 2017;24:12-19.
26. Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7:S32-S43.
27. Lafata JE, Williams LK, Ben Menachem T, Moon C, Divine G. Colorectal carcinoma screening procedure use among primary care patients. Cancer. 2005;104:1356-1361.
28. Etzioni DA, Yano EM, Rubenstein LV, et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum. 2006;49:1002-1010.
29. Cooper LA, Roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race [see comment]. Ann Intern Med. 2003;139:907-915.
30. Liss DT, Brown T, Lee JY, et al. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients. Cancer Causes Control. 2016;27:881-887.
31. Heidenreich PA, Shlipak MG, Geppert J, McClellan M. Racial and sex differences in refusal of coronary angiography. Am J Med. 2002;113:200-207.
32. Sedlis SP, Fisher VP, Tice D, Esposito R, Madmon L, Steinberg EH. Racial differences in performance of invasive cardiac procedures in a Department of Veterans Affairs Medical Center. J Clin Epidemiol. 1997;50:899-901.
33. Oddone EZ, Horner RD, Diers T, et al. Understanding racial variation in the use of carotid endarterectomy: the role of aversion to surgery. J Natl Med Assoc. 1998;90:25-33.
34. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med. 1999;341:1661-1669.
35. Whittle J, Conigliaro J, Good CB, Joswiak M. Do patient preferences contribute to racial differences in cardiovascular procedure use? J Gen Intern Med. 1997;12:267-273.
36. Zhu CW, Livote EE, Ross JS, Penrod JD. A random effects multinomial logit analysis of using Medicare and VA healthcare among Veterans with dementia. Home Health Care Serv Q. 2016;29:91-104.
37. Ross JS, Keyhani S, Keenan PS, et al. Dual use of Veterans Affairs services and use of recommended ambulatory care. Med Care. 2008;46:309-316.
38. Petersen LA, Byrne MM, Daw CN, Hasche J, Reis B, Pietz K. Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled Veterans. Health Serv Res. 2010;45:762-791.
39. Hynes DM, Koelling K, Stroupe K, et al. Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care. 2007;45:214-223.
40. Humensky J, Carretta H, de Groot K, Brown MM, Tarlov E, Hynes DM. Service utilization of veterans dually eligible for VA and Medicare fee-for-service: 1999-2004. Medicare Medicaid Res Rev. 2012;2:E1-E22.
41. Berke EM, West AN, Weeks WB. Practical and policy implications of using different rural-urban classification systems: a case study of inpatient service. J Rural Health. 2016;25:259-266.
42. Maciejewski ML, Birken S, Perkins M, Burgess JF Jr, Sharp N, Liu CF. Medicare managed care enrollment by disability-eligible and age-eligible Veterans. Med Care. 2009;47:1180-1185.
43. Morris AL, Vito AA, Bomba MR, Bentley JM. The impact of a quality assessment program on the practice behavior of general practitioners: a follow-up study. J Am Dent Assoc. 1989;119:705-709.
44. Ferrat E, Le Breton J, Veerabudun K, et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer. 2013;109:1437-1444.
45. Wong ES, Wang V, Liu F, Herbert PL, Maciejewski ML. Do Veterans Health Administration enrollees generalize to other populations? Med Care Res Rev. 2016;73:493-507.